Post by
culater on Nov 22, 2010 2:30pm
BIONICHE LIFE SCIENCES INC - BNC:TSX
t.bnc, Someone posted to catch the wave up on this some time back at $ 1.80. Seems this stock is suffering from the same symptoms as ISA. They received a milestone payment of 4 million dollars for a successful phase 111 trial recently and now selling 20 million new shares to increase cash. On the notice of a new share issue it has dropped to 1.47 and appears to be going lower. As I have mentioned before, the best play on small pharma stocks for us retail investors is to follow the chart, do some DD, buy on the drops and wait for pending news to sell.
culater